INVERSINE
INVERSINE: A Novel Anti-Cancer Drug for Non-Small Cell Lung Cancer Introduction Non-Small Cell Lung Cancer (NSCLC) is the most commonly diagnosed type of lung cancer, accounting for approximately 85% of all lung cancers. It is an aggressive disease with limited treatment options and a poor prognosis. In recent years, there has been an increased focus […]